Health Union, a leader in patient-centered market research, has released its 2024 findings from the “In America” and “Patient Experience” syndicated studies. The new data, drawn from over 37,000 respondents across more than 50 chronic and rare health conditions, provides an evolved and comprehensive perspective on patient journeys. Key areas of focus include treatment satisfaction, quality of life, and unmet patient needs.
For more than a decade, Health Union has been at the forefront of delivering actionable insights into patient experiences, equipping pharmaceutical companies, healthcare organizations, and media agencies with valuable data to inform strategic decisions. The 2024 findings continue this tradition, offering fresh perspectives on what it means to live with complex health conditions.
A Decade of Patient-Centered Insights
Health Union’s syndicated market research has been instrumental in helping healthcare organizations understand emerging trends, patient challenges, and gaps in care. Through large-scale surveys and robust sample sizes, these studies provide a comprehensive view of healthcare journeys, offering actionable insights that go beyond traditional data sources.
“The unique strength of our syndicated research is its ability to connect directly with the real people behind the data, capturing their experiences, needs, and challenges,” said Lauren Lawhon, President & COO of Health Union. “This allows healthcare organizations to make decisions that are both patient-centered and data-driven.”
What’s New in 2024: Enhanced Research Products
The 2024 updates to Health Union’s syndicated research bring enhanced perspectives, deepening the understanding of patient experiences across a wide array of chronic and rare conditions. This year’s findings focus on critical aspects of patient care, providing organizations with the tools to make more informed decisions.
In America Series: The “In America” survey, Health Union’s flagship quantitative study, offers a broad overview of patient journeys across 50+ health conditions. With data on symptoms, treatment history, and pharmaceutical brand awareness, this series captures both shared and unique elements of healthcare journeys. It provides actionable insights to guide marketing strategies and patient persona development.
Patient Experience Reports: These in-depth reports delve into the attitudes, experiences, and actions of patients. By focusing on quality of life, unmet needs, disease burden, and healthcare provider relationships, the “Patient Experience” series offers detailed insights into the lived experiences of patients. Quota sampling ensures diverse representation, providing a nuanced understanding of various patient subgroups.
Key Benefits and Applications for Clients
Health Union’s 2024 syndicated research offers a wealth of insights that healthcare organizations can use to refine their strategies. Key features of the new data include:
Comprehensive Coverage: The 2024 studies cover over 50 health conditions, including high-impact conditions like advanced breast cancer, Alzheimer’s, epilepsy, macular degeneration, schizophrenia, obesity, NASH, hidradenitis suppurativa, and prostate cancer. This wide range of conditions allows organizations to explore diverse patient journeys and identify new engagement opportunities.
Rich, Multi-Dimensional Insights: Combining quantitative data with qualitative responses, the studies capture both broad patterns and nuanced patient experiences. This blend of data supports empathetic, patient-centered decision-making.
Versatile Applications: Health Union’s research products offer flexibility for various use cases, from supporting custom research and enriching journey maps to comparing patient experiences across therapeutic areas.
Related topics:
